Sentence examples for proof-of-concept model from inspiring English sources

(Anyone submitting a perpetual motion patent application would still be required to provide a proof-of-concept model).

The result is a creative proof-of-concept model that can predict which wounds need special care.

The proof-of-concept model includes evaluation of modifications to the building and its defenses.

The desktop proof-of-concept model and the focus of this paper, Atlas Lite, is used to test the basics of Atlas's novel actuation, sensing, and control technologies.

On the basis of the Euler Bernoulli beam as a proof-of-concept model a procedure for the assessment of the system's robustness is shown.

Our proof-of-concept model consists to determine the anchorage of synthetic peptides in a bilayer enveloping magnetic beads by revealing their presence via fluorescently labeled immunoglobulins elicited against the native proteins of the said exposed peptides.

We demonstrate the imaging of engineered cells in vivo in proof-of-concept models of gastrointestinal and tumour localization, and develop acoustically distinct reporters that enable multiplexed imaging of cellular populations.

Computational nucleic acids are constructed as modular tuneable units, where different components of one system can be substituted with alternative parts as demonstrated in proof-of-concept models of simple computational units [14, 15] and as synthetic devices integrated within living cells [4 6].

Transcriptomic analyses provide a promising means of furthering the field of environmental toxicology, with several applications having been realized in full and other applications, including biomarker development, having proof-of-concept models in place [ 14].

The proof-of-concept simulation model described in this study has potential as a tool for understanding factors contributing to dengue spread as well as planning and optimizing dengue control, including reducing the Ae. aegypti vector population and for estimating the effectiveness and cost-effectiveness of future vaccination programmes.

This work is a first proof-of-concept example of an integrated model-based approach for evaluation of toxicity, efficacy, and cost effectiveness during early clinical development.